Faculty of Biology, Medicine and Health

The University of Manchester

This project is no longer listed on FindAPhD.com and may not be available.

Click here to search FindAPhD.com for PhD studentship opportunities

  Central regulation of appetite and body weight

  Prof S Luckman  Applications accepted all year round  Self-Funded PhD Students Only

About the Project

Our laboratory is interested in how the brain regulates appetite and body weight. We use a multi-disciplined approach; studying gene expression, cellular function, brain connectivity and behaviour. All of research uses transgenic mouse models which allow us to investigate and modulate the activity of specific neurones and their connections.

The student will discover central pathways which control food intake. Resolving these circuits will not only expand our understanding of how ingestive behaviour is regulated, but it will also inform design of novel medications with improved efficacy and patient compliance.

Entry Requirements

Candidates are expected to hold (or be about to obtain) a minimum upper second class honours degree (or equivalent) in neuroscience or physiology. Only candidates with prior relevant research experience are encouraged to apply.

How To Apply

For information on how to apply for this project, please visit the Faculty of Biology, Medicine and Health Doctoral Academy website (https://www.bmh.manchester.ac.uk/study/research/apply/). Informal enquiries may be made directly to the primary supervisor. On the online application form select the appropriate subject title.

For international students, we also offer a unique 4 year PhD programme that gives you the opportunity to undertake an accredited Teaching Certificate whilst carrying out an independent research project across a range of biological, medical and health sciences.

Equality, Diversity and Inclusion

Equality, diversity and inclusion is fundamental to the success of The University of Manchester, and is at the heart of all of our activities. The full Equality, diversity and inclusion statement can be found on the website https://www.bmh.manchester.ac.uk/study/research/apply/equality-diversity-inclusion/”

Biological Sciences (4) Medicine (26)

Funding Notes

Applications are invited from self-funded students. This project has a Band 3 fee. Details of our different fee bands can be found on our website (https://www.bmh.manchester.ac.uk/study/research/fees/).

References

Worth, A.A., Shoop, R., Tye, K., Feetham, C.H., D’Agostino, G., Dodd, G.T., Reimann, F., Gribble, F.M., Beebe, E.C., Dunbar, J.D., Alexander-Chacko, J.T., Sindelar, D.K., Coskun, T., Emmerson, P.J. and Luckman, S.M., 2020, The cytokine GDF15 signals through a population of brainstem cholecystokinin neurons to mediate anorectic signalling. eLife 9: e55164 (online Jul 29) (doi: 10.7554/eLife.55164).

Jones, E.S., Nunn, N., Chambers, A.P., Østergaard, S., Wulff, B.S. and Luckman, S.M., 2019, Modified peptide YY molecule attenuates the activity of NPY/AgRP neurons and reduces food intake in mice. Endocrinology 160: 2737-2747 (online May 10) (doi: 10.1210/en.2019-00100).

Khodai, T.J., Nunn, N., Worth, A.A., Feetham, C.H., Belle, M.D.C., Piggins, H.D. and Luckman, S.M, 2018, PACAP neurons in the ventromedial hypothalamic nucleus are glucose inhibited and their selective activation induces hyperglycaemia. Front. Endocrinol. 9: 632 (online Oct 30) (doi: 10.3389/fendo.2018.00632).

Schéle, E., Cook, C., Le May, M., Bake, T., Luckman, S.M. and Dickson, S.L., 2017, Central administration of ghrelin induces conditioned avoidance in rodents. European Neuropsychopharmacology 27: 809-815 (online Jun 21) (doi: 10.1016/j.euroneuro.2017.05.001).

Dodd, G.T., Worth, A.A., Nunn, N., Korpal, A.K., Bechtold, D.A., Allison, M.B., Myers, M.G., Statnick, M.A. and Luckman, S.M., 2014,The thermogenic effect of leptin is dependent on a distinct population of prolactin-releasing peptide (PrRP) neurons in the dorsomedial hypothalamus. Cell Metab. 20: 639-649 (online Aug 28) (doi: 10.1016/j.cmet.2014.07.022).

Where will I study?

Search Suggestions
Search suggestions

Based on your current searches we recommend the following search filters.

Faculty of Biology, Medicine and Health

Tackle real world challenges, make a difference, and elevate your career with postgraduate research in the Faculty of Biology, Medicine and Health at Manchester. From biochemistry to neuroscience, cancer sciences to medicine, audiology to mental health and everything in between, we offer a wide range of postgraduate research projects, programmes and funding which will allow you to immerse yourself in an area of research you’re passionate about.

Why study at Faculty of Biology, Medicine and Health?

Ranked the best place to live in the UK (The Economist Global Liveability Index, 2022), Manchester boasts world-class culture, iconic sports, a thriving music and food scene, and much more. It's not just a place to research, it's a place to call home.

Experience PhD life as part of a diverse postgraduate research community of more than 1,000 postgraduate researchers at the 29th most international university in the world (Times Higher Education, 2023).

With 93% of research activity at the University rated as 'world-leading' or 'internationally excellent' (Research Impact Framework, 2021), you'll get the chance to have an impact on global health and science challenges.

1000+

postgraduate students

214

PhDs

6

ranked in UK - QS (2025)

Manchester  United Kingdom

main campus

Upcoming Open Days & Webinars

16

Sep 2024

The University of Manchester

Postgraduate Research Webinars - Biology, Medicine and Health

 Manchester

25

Sep 2024

The University of Manchester

Postgraduate Research Open Day - Biology, Medicine and Health

 Manchester


About Faculty of Biology, Medicine and Health

At Manchester, postgraduate researchers are at the heart of our mission to tackle pressing global challenges in biological, medical and healthcare sciences - and you could be too.

By choosing Manchester for your postgraduate research, you’ll be joining a university with an exceptional research reputation, where 93% of research is world-leading or internationally excellent (REF, 2021) and where your work will have real-world impact.

You’ll research in world-class facilities alongside leading experts at the forefront of innovation, collaborating across disciplines to pioneer new treatments, advance scientific knowledge, and improve healthcare globally.

Supported by our dedicated Doctoral Academy and strong industry links, you'll experience PhD life in a vibrant, welcoming and diverse postgraduate research community.

And you’ll leave with the specialist knowledge, research experience and transferable skills that will shape your future in academia, research or industry.





Main campus

The University of Manchester

Manchester

North West

United Kingdom

PhD saved sucessfully

(MB-PhD) Gene regulatory networks driving metastatic progression in oesophageal adenocarcinoma

Oesophageal adenocarcinoma (OAC) incidence is increasing and yet survival rates remain very poor. There are limited treatment options, especially for metastatic disease, which is especially problematic as patients usually present with late stage disease. Read more
More details

(MB-PhD) MYST Histone Acetyltransferases as Therapeutic Targets in Acute Myeloid Leukaemia

Cytotoxic chemotherapy has been the standard of care for treatment of acute myeloid leukaemia (AML) for the last 50 years. Unfortunately, more often than not, it fails to cure patients, and the 5 years survival rate for all-comers with AML is only around 20%. Read more
More details

(MB-PhD)Immunomodulation in multiple myeloma

Multiple myeloma is a devastating B-cell malignancy for which there is no cure. The development of immunomodulatory drugs (IMiDs) has proved transformative to multiple myeloma care, however, their remain unanswered questions related to the mechanism of action of this important drug class. Read more
More details

(MRC DTP CASE) Developing a cortical organoid model of genetic autism to understand early brain development

Neurodevelopmental conditions including autism and ADHD affect 4-8% of the paediatric population. These conditions present in the preschool period, are highly heritable and can severely affect quality of life, academic and occupational functioning. Read more
More details

(MRC DTP CASE) Drug Binding on human G-Protein Coupled Receptors under Tension-Altered Biomechanics in Diseases

Integral membrane proteins (MPs) constitute a significant part of the genome and are targets of ~30% of therapeutics. However, structural and functional understanding of these proteins often lags behind that of their soluble counterparts. Read more
More details

(MRC DTP) Circadian mechanisms in psoriasis: translating genomic and computational analysis to clinical care.

Despite numerous lines of evidence supporting a role for the circadian clock regulating multiple immunological axes, the dominant cell type driving rhythmic disease expression in psoriasis remains undetermined and there has been no progress on time-of-day regulation of psoriasis. Read more
More details

(MRC DTP) Combinatorial targeting of multiple disease mechanisms in drug-resistant epilepsy using microRNA inhibitors

Epilepsy is one of the most common chronic neurological diseases, affecting ~70 million people worldwide. Epilepsy is characterised by susceptibility to spontaneous seizures, and can also include challenges with cognition, sleep and mental health. Read more
More details

(MRC DTP) Controlling G-protein coupled receptors to understand and treat obesity

The socioeconomic burden of obesity is ever increasing. Therefore, deciphering the neural substrates that control energy intake, expenditure and partitioning is an important step to developing novel treatments to reduce obesity rates. Read more
More details

(MRC DTP) Decoding the Brain-Immune Axis: Neuronal Circuitry and Metabolic Impact on Immune Responses

The immune system's response is intricately linked to nutritional status, with fasting and caloric restriction reducing inflammatory damage and extreme dietary perturbations increasing susceptibility to infection and inflammatory disorders. Read more
More details

(MRC DTP) Developing novel therapeutics to target splicing factor mutant myeloid malignancies

Aberrant RNA splicing is a key pathogenic event in several cancers including blood cancers. Blood cancer patients with splice factor mutations have worse overall survival than splice factor wild-type patients, highlighting the need for better treatment strategies for this group of patients. Read more
More details

(MRC DTP) Dissecting immune networks in barrier tissues and beyond

The immune system maintains tissue health within a variety of tissues and organs throughout the body, from mucosal barrier sites (such as the oral cavity, gut and lung) to the membranes that line the brain (meninges). Read more
More details

(MRC DTP) How do B cell functions shape the host-commensal dialog at the oral mucosa?

Maintaining immune homeostasis at the oral barriers of the mouth is a considerable challenge. Commensal organisms at these sites must be controlled whilst effectively responding to environmental and pathogen challenges. Read more